Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by willfs72on Dec 09, 2020 12:50am
137 Views
Post# 32065053

RE:RE:RE:RE:OMG - LONGS CHECK THIS OUT!!!!

RE:RE:RE:RE:OMG - LONGS CHECK THIS OUT!!!!Shareswapper,

I like where you are going with your posts, but one correction... The CEO did buy 273,556 shares on September 11th, but it was at $ 0.035 US. Whoever filled out the forms, or updated the system must have made a data entry error!

I remember seeing the shares cross on the OTCBB... and it was at 3 1/2 cents per share. 


He couldn't pay more for shares if he wanted to, you always pay the market value.
Nonetheless, when executives acquire shares in the public market, they earn my trust!
<< Previous
Bullboard Posts
Next >>